[1]
Coronavirus disease 2019 (COVID-19), Situation Report – 61;. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200321-sitrep-61-covid-19.pdf?sfvrsn=6aa18912_2 Accessed 22 March 2020.
[2]
Nandy A, Basak SC. The Wuhan epidemic 2019 - A commentary; Technical Report No. 20-01: 2019-nCoV;. https://www.researchgate.net/publication/338832597_The_Wuhan_epidemic_2019_-A_commentary
Current Computer-Aided Drug Design
Title:COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace?
Volume: 17 Issue: 1
Author(s): Subhash C. Basak and Lemont B. Kier
Affiliation:
Export Options
About this article
Cite this article as:
Basak C. Subhash and Kier B. Lemont, COVID-19 Pandemic: How can Computer-assisted Methods help to Rein in this Global Menace?, Current Computer-Aided Drug Design 2021; 17 (1) . https://dx.doi.org/10.2174/157340991701210112103215
DOI https://dx.doi.org/10.2174/157340991701210112103215 |
Print ISSN 1573-4099 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6697 |
4
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Insights into Resveratrol and Its Analogs as SARS-CoV-2 (COVID-19) Protease Inhibitors
Coronaviruses Forecasting of COVID-19 Cases in India: A Predictive Study
Current Immunology Reviews (Discontinued) Triazavirin - Potential Inhibitor for 2019-nCoV Coronavirus M Protease: A DFT Study
Current Molecular Medicine COVID-19: Update on Pathogenesis and Treatment Strategies
Current Immunology Reviews (Discontinued) Structural Biology Aids the Research of New Anti-COVID-19 Drugs
Current Organic Synthesis Alterations in Clinical Characteristics of Blood Donors Post COVID-19 Recovery
Current Pharmaceutical Design Adjuvant Therapies of COVID-19 - A Literature Review
Coronaviruses SARS-CoV-2: Origin, Pathogenesis and Therapeutic Interventions
Coronaviruses Drug Repositioning: A Smart Approach for Combating SARS-CoV-2
Anti-Infective Agents Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion
Infectious Disorders - Drug Targets Patents Review in siRNA Delivery for Pulmonary Disorders
Recent Patents on Drug Delivery & Formulation Non-Respiratory Manifestations of COVID-19 and Pathophysiological Evidences
New Emirates Medical Journal Drug Design Targeting the Main Protease, the Achilles Heel of Coronaviruses
Current Pharmaceutical Design Medicinal Applications of Cannabinoids Extracted from Cannabis sativa (L.): A New Route in the Fight Against COVID-19?
Current Pharmaceutical Design Cyclophilin function in Cancer; lessons from virus replication
Current Molecular Pharmacology A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case
Infectious Disorders - Drug Targets The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19
Current Psychopharmacology The Perfect Storm: A Rheumatologist's Point of View on COVID-19 Infection
Current Rheumatology Reviews Drug Re-purposing Approach and Potential Therapeutic Strategies to Treat COVID-19
Mini-Reviews in Medicinal Chemistry Selection of Active Antiviral Compounds Against COVID-19 Disease Targeting Coronavirus Endoribonuclease Nendou/NSP15 Via Ligandbased Virtual Screening and Molecular Docking
Letters in Drug Design & Discovery